Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gastrointestinal Associates (GIA) is a premier gastroenterology practice and clinical research center based in Knoxville, Tennessee, recognized for its long history of innovation in digestive health. Founded in 1971 by Dr. Bergein Overholt, the inventor of the flexible fiberoptic sigmoidoscope, GIA established the first licensed endoscopic ambulatory surgery center in the United States in 1986. The practice provides comprehensive care for gastrointestinal, liver, and pancreatic disorders and is a national leader in clinical research, participating in numerous Phase 1-3 trials for conditions such as inflammatory bowel disease (IBD) and Barrett's esophagus. GIA operates multiple state-of-the-art endoscopy centers and offers specialized programs like GIA 180 for non-surgical weight management. Through its commitment to research and advanced technology, the company remains at the forefront of gastrointestinal medicine and patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gastrointestinal Associates.